Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2125405.
- Also identified by PMC identifier 1793124.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We used an oral topical antibiotic preparation to try and prevent oropharyngeal carriage of Pseudomonas aeruginosa in patients with cystic fibrosis. Ten of 15 patients treated with a two week course of intravenous ceftazidime together with a 90 day course of an antibiotic containing gel continued to carry P aeruginosa in the oropharynx.
Medical subject headings
- Carrier State
- Ceftazidime
- Cystic Fibrosis
- Pseudomonas Infections